Mitochondrial DNA-activated cGAS-STING pathway in cancer: Mechanisms and therapeutic implications

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Mitochondrial DNA (mtDNA) is integral to innate immunity via the cyclic GMP-AMP synthase (cGAS)-STING pathway.
• mtDNA interacts with the cGAS-STING pathway and neutrophil extracellular traps (NETs) in cancer progression.
• Autophagy regulates these interactions by clearing damaged mitochondria and degrading cGAS.

Purpose of the Study:

• To review the role of mtDNA in cancer immunity and inflammation.
• To explore therapeutic strategies targeting mtDNA leakage and the cGAS-STING pathway.
• To discuss the potential of converting 'cold tumors' to 'hot tumors'.

Main Methods:

• Literature review of studies on mtDNA, cGAS-STING, NETs, and autophagy in cancer.
• Analysis of tumor microenvironmental factors influencing mtDNA release.
• Exploration of current and future cancer drug development strategies.

Main Results:

• mtDNA leakage activates the cGAS-STING pathway, promoting NETosis and tumor cell death.
• Tumor microenvironment factors exacerbate mtDNA leakage and inflammation.
• Targeting mtDNA-cGAS-STING interactions can potentially enhance anti-tumor immunity.

Conclusions:

• mtDNA plays a complex role in cancer immunity, offering therapeutic targets.
• Leveraging mtDNA leakage can convert immunologically 'cold' tumors into 'hot' ones.
• Further research into targeted therapies and novel methodologies is warranted.